1. Home
  2. GLBE vs ABVX Comparison

GLBE vs ABVX Comparison

Compare GLBE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLBE
  • ABVX
  • Stock Information
  • Founded
  • GLBE 2013
  • ABVX 2013
  • Country
  • GLBE Israel
  • ABVX France
  • Employees
  • GLBE N/A
  • ABVX N/A
  • Industry
  • GLBE Computer Software: Prepackaged Software
  • ABVX
  • Sector
  • GLBE Technology
  • ABVX
  • Exchange
  • GLBE Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • GLBE 6.0B
  • ABVX 5.3B
  • IPO Year
  • GLBE 2021
  • ABVX N/A
  • Fundamental
  • Price
  • GLBE $35.68
  • ABVX $84.01
  • Analyst Decision
  • GLBE Buy
  • ABVX Strong Buy
  • Analyst Count
  • GLBE 14
  • ABVX 8
  • Target Price
  • GLBE $48.71
  • ABVX $90.63
  • AVG Volume (30 Days)
  • GLBE 1.7M
  • ABVX 1.2M
  • Earning Date
  • GLBE 08-13-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • GLBE N/A
  • ABVX N/A
  • EPS Growth
  • GLBE N/A
  • ABVX N/A
  • EPS
  • GLBE N/A
  • ABVX N/A
  • Revenue
  • GLBE $843,642,000.00
  • ABVX $7,073,400.00
  • Revenue This Year
  • GLBE $28.25
  • ABVX $25.23
  • Revenue Next Year
  • GLBE $24.61
  • ABVX N/A
  • P/E Ratio
  • GLBE N/A
  • ABVX N/A
  • Revenue Growth
  • GLBE 33.30
  • ABVX N/A
  • 52 Week Low
  • GLBE $26.64
  • ABVX $4.77
  • 52 Week High
  • GLBE $63.69
  • ABVX $92.91
  • Technical
  • Relative Strength Index (RSI)
  • GLBE 56.96
  • ABVX 67.94
  • Support Level
  • GLBE $32.52
  • ABVX $82.72
  • Resistance Level
  • GLBE $37.37
  • ABVX $91.30
  • Average True Range (ATR)
  • GLBE 1.14
  • ABVX 3.62
  • MACD
  • GLBE 0.34
  • ABVX -1.13
  • Stochastic Oscillator
  • GLBE 69.68
  • ABVX 47.89

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: